PMID: 8592656Nov 1, 1995Paper

Human MCAF gene transfer enhances the metastatic capacity of a mouse cachectic adenocarcinoma cell line in vivo

Pharmaceutical Research
E NakashimaK Matsushima

Abstract

To evaluate the effect of monocyte chemotactic and activating factor (MCAF/MCP-1/JE) on tumor progression and metastasis. Cachexia-inducing adenocarcinoma cells (cell line colon 26, clone 20) were transfected with either a control plasmid or MCAF expression vector. Spontaneous lung metastases were determined in mouse. The production of MCAF reached 0.4 ng/ml in vitro when transfectant cells were cultured at a cell density of 5 x 10(4) cells/ml for 3 days. Transfection of MCAF expression vector did not affect the growth rate in vitro. Also, after MCAF-transfection, the size of tumors after intra-footpad inoculation was similar to that of the parental cells. When the primary tumors were resected on the 10th day after inoculation, the incidence of spontaneous lung metastasis was less than 20% in both cells. The number of endothelial cells in the primary tumor rapidly increased from the 10th to the 14th day after inoculation, as revealed by immunohistochemical staining. In accordance with enhanced angiogenesis, the incidence rates of spontaneous metastasis increased when the primary tumors were resected on the 14th day after inoculation. Moreover, the spontaneous lung metastases were augmented in the animals injected with MCAF-tran...Continue Reading

Citations

Mar 27, 2002·Nature Reviews. Immunology·Bernhard HomeyAlbert Zlotnik
Jul 25, 2009·Clinical & Experimental Metastasis·Munehisa TakahashiTomoko Okada
Apr 24, 2010·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Deise Souza Vilas BôasJean Nunes dos Santos
May 19, 2016·Oncotarget·Ran CuiXiang-Lin Tan
Jul 9, 2005·International Journal of Cancer. Journal International Du Cancer·Melanie MestdagtChristine Gilles
Sep 6, 2012·Immunotherapy·Elham Mohit, Sima Rafati
Jun 27, 2003·Cornea·Balamurali K AmbatiJayakrishna Ambati
Jan 10, 2003·Circulation Journal : Official Journal of the Japanese Circulation Society·Tianshu ZhangJun Amano
May 22, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M NesbitM Herlyn
Oct 7, 2011·Journal of Oncology·Jennifer SullivanHwyda A Arafat
Sep 5, 2002·Nature Reviews. Immunology·Ann Richmond
Aug 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christine E BrownMichael C Jensen
Jun 5, 2014·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Ronit Vogt SionovZvi Granot
Oct 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Srinivasan MadhusudanAdrian L Harris
May 26, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Edmund K MoonSteven M Albelda
Nov 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tsuyoshi KurodaKazuaki Chayama
Dec 5, 1998·Journal of Immunological Methods·J M WangS Su
May 12, 2021·Cancer Metastasis Reviews·Élora MidavainePhilippe Sarret

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.